
Ask a doctor about a prescription for VASCORLEN 7.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Vascorlen 7.5mg film-coated tablets EFG
Ivabradine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Vascorlen (ivabradine) is a heart medicine used to treat:
About stable angina pectoris (commonly known as "angina"):
Stable angina pectoris is a heart disease that occurs when the heart does not receive enough oxygen. It usually appears between the ages of 40 and 50. The most frequent symptom of angina is chest pain or discomfort. Angina is more likely to occur when the heart beats faster in situations such as exercise, emotion, exposure to cold, or after eating. This increase in heart rate can cause chest pain in people with angina.
About chronic heart failure:
Chronic heart failure is a heart disease that occurs when your heart cannot pump enough blood to the rest of your body. The most frequent symptoms of heart failure are difficulty breathing, fatigue, tiredness, and swelling of the ankles.
How does Vascorlen work?
Vascorlen works mainly by reducing the heart rate by some beats per minute. This reduces the heart's need for oxygen, especially in situations where angina attacks are more likely to occur. In this way, Vascorlen helps control and reduce the number of angina attacks.
Additionally, since elevated heart rate negatively affects heart function and vital prognosis in patients with chronic heart failure, the specific heart rate-lowering action of ivabradine helps improve heart function and vital prognosis in these patients.
Consult your doctor or pharmacist before starting to take Vascorlen:
If you meet any of these conditions, consult your doctor immediately before or during treatment with Vascorlen.
Vascorlen is not intended for use in children and adolescents under 18 years of age.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Make sure to inform your doctor if you are taking any of the following medicines, as a dose adjustment of Vascorlen or monitoring may be necessary:
Avoid grapefruit juice during treatment with Vascorlen.
Do not take Vascorlen if you are pregnant or plan to become pregnant (see "Do not take Vascorlen").
If you are pregnant and have taken Vascorlen, consult your doctor.
Do not take Vascorlen if you are of childbearing age and do not use reliable contraceptive methods (see "Do not take Vascorlen").
Do not take Vascorlen if you are breastfeeding (see "Do not take Vascorlen"). Talk to your doctor if you are breastfeeding or plan to start breastfeeding, as breastfeeding should be interrupted if you are taking Vascorlen.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Vascorlen may cause transient visual phenomena (a brief increase in brightness, usually caused by sudden changes in light intensity). If this happens, be careful when driving or using machinery in situations where sudden changes in light intensity may occur, especially when driving at night.
If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Vascorlen should be taken with breakfast and dinner.
If you are being treated for stable angina pectoris
The initial dose should not exceed one 5 mg Vascorlen tablet twice a day. If you still have symptoms of angina and have tolerated the 5 mg dose twice a day well, the dose may be increased. The maintenance dose should not exceed 7.5 mg twice a day. Your doctor will prescribe the correct dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g., if you are an elderly patient), your doctor may prescribe half the dose, i.e., half a 5 mg Vascorlen tablet (corresponding to 2.5 mg of ivabradine) in the morning and half a 5 mg tablet in the evening.
If you are being treated for chronic heart failure
The recommended initial dose is one 5 mg Vascorlen tablet twice a day, which may be increased if necessary to one 7.5 mg Vascorlen tablet twice a day. Your doctor will decide the suitable dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g., if you are an elderly patient), your doctor may prescribe half the dose, i.e., half a 5 mg Vascorlen tablet (corresponding to 2.5 mg of ivabradine) in the morning and half a 5 mg tablet in the evening.
The 5 mg tablet can be divided into equal doses.
If you take moreVascorlenthan you should
An excessive dose of Vascorlen may make you feel short of breath or tired because your heart is beating too slowly. If this happens, contact your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service at 91 562 04 20, indicating the medication and the amount ingested.
If you forget to takeVascorlen
If you forget to take a dose of Vascorlen, take the next dose at the scheduled time. Do not take a double dose to make up for the forgotten doses.
If you stop takingVascorlen
Generally, the treatment of angina pectoris or chronic heart failure is for life, so you should consult your doctor before stopping this medication.
If you think the action of Vascorlen is too strong or too weak, tell your doctor or pharmacist.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The frequency of the possible side effects listed below is defined using the following system:
Very common: may affect more than 1 in 10 people.
Common: may affect up to 1 in 10 people.
Uncommon: may affect up to 1 in 100 people.
Rare: may affect up to 1 in 1,000 people.
Very rare: may affect up to 1 in 10,000 people.
Frequency not known: cannot be estimated from the available data.
The most frequent adverse reactions with this medicine are dose-dependent and related to its mechanism of action:
Very common:
Transient visual phenomena (brief moments of increased brightness, usually caused by sudden changes in light intensity). They can also be described as a halo, flashes of color, decomposition of the image, or multiple images. These usually appear during the first two months of treatment, after which they may occur repeatedly and resolve during or after treatment.
Common:
Modification of heart function (symptoms are a slowing of the heart rate). This occurs especially in the first 2 to 3 months after starting treatment.
Other adverse effects have also been reported:
Common:
Rapid irregular heart contraction, sensation of abnormal heartbeat, uncontrolled blood pressure, headache, dizziness, and blurred vision (cloudy vision).
Uncommon:
Palpitations and extra heartbeats, sensation of dizziness (nausea), constipation, diarrhea, abdominal pain, sensation of spinning (vertigo), difficulty breathing (dyspnea), muscle cramps, changes in laboratory tests: elevated blood uric acid levels, excess eosinophils (a type of white blood cell), and elevated creatinine levels in blood, skin rash, angioedema (such as facial swelling, tongue or throat swelling, difficulty breathing or swallowing), low blood pressure, fainting, feeling of tiredness, feeling of weakness, abnormal electrocardiogram, double vision, visual disturbance.
Rare:
Hives, itching, skin redness, malaise.
Very rare:
Irregular heartbeats.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the carton and blister after "EXP". The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
One film-coated tablet contains 7.5 mg of ivabradine (equivalent to 8.085 mg of ivabradine as hydrochloride).
Core of the tablet
Lactose monohydrate
Microcrystalline cellulose
Sodium croscarmellose
Colloidal anhydrous silica
Magnesium stearate
Coating
Hypromellose 6cp (E464)
Titanium dioxide (E171)
Macrogol 6000 (E1521)
Magnesium stearate (E470b)
Glycerol (E422)
Appearance of the product and contents of the pack
White, round, biconvex film-coated tablet with "7.5" engraved on one side and smooth on the other.
The tablets are presented in aluminum/aluminum blisters of 14, 28, 56, 84, 98, 100, or 112 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Biopharm Ltd.
5 Triaditza Str. Entrance A, Oborishte district,
Sofia 1000,
Bulgaria
Manufacturer
Genepharm S.A.
18 km Marathon Avenue
153 51 Pallini
Greece
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Bluefish Pharma S.L.U.,
Ribera del Loira nº 46, Campo de las Naciones,
28042 Madrid,
Spain
Member State | Medicine name |
Portugal | Vascorlen |
Spain | Vascorlen 7.5 mg film-coated tablets EFG |
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of VASCORLEN 7.5 mg FILM-COATED TABLETS in October, 2025 is around 43.27 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for VASCORLEN 7.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.